We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FICO:NYSEFair Isaac Corporation Analysis

Data as of 2026-03-10 - not real-time

$1,409.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Fair Isaac Corporation (FICO) is trading at $1,409.5, well above its DCF‑derived fair value of $532, indicating a substantial premium. The stock sits below its 20‑day ($1,378.9), 50‑day ($1,485.8) and 200‑day ($1,598.5) moving averages, and the RSI of 48 suggests a neutral momentum with no clear overbought signal. However, the MACD histogram is positive (+19.2) and the MACD line sits above the signal line, hinting at a short‑term bullish tilt despite an overall bearish trend direction and decreasing volume. Support sits near $1,193.1 and resistance around $1,494, leaving limited upside on the near term.
The fundamentals paint a more optimistic picture: revenue grew 16% YoY to $2.06 bn, operating margin is a robust 45.7%, and free cash flow exceeds $573 m. Analysts are largely positive, with a consensus “Buy” rating and a target median price of $2,010, while the company announced a $1.5 bn share‑repurchase program. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 77) and a 38.8% upside potential relative to the current price add further bullish color, though the high P/E of 52 versus an industry average of 36.9 signals notable valuation risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish bias
  • Decreasing volume trend reducing short‑term liquidity
  • Positive MACD histogram suggesting limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • $1.5 bn share‑repurchase authorization supporting price
  • Analyst consensus “Buy” with median target above current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable cash flow generation and low debt‑to‑equity profile
  • Leadership in analytics and credit‑scoring market with global reach
  • Growth‑oriented business model despite current valuation premium

Key Metrics & Analysis

Financial Health

Revenue Growth16.40%
Profit Margin31.89%
P/E Ratio52.3
ROA34.76%
P/B Ratio-18.5
Op. Cash Flow$758.9M
Free Cash Flow$573.2M
Industry P/E36.9

Technical Analysis

TrendBearish
RSI48.0
Support$1,193.10
Resistance$1,494.00
MA 20$1,378.87
MA 50$1,485.82
MA 200$1,598.47
MACDBullish
VolumeDecreasing
Fear & Greed Index77.13

Valuation

Fair Value$532.09
Target Price$1,955.76
Upside/Downside38.76%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.94
Volatility48.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.